Showing results (11-20 of 97) with videos related to
Sort By:
Pageof 10
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2004
Fecal multiple molecular tests to detect colorectal cancer in stoolDaniele Calistri, Claudia Rengucci, Renato Bocchini, et al.International Journal of Molecular Sciences|August 1, 2014
Discrepancies between VEGF -1154 G>A polymorphism analysis performed in peripheral blood samples and FFPE tissueGiorgia Marisi, Alessandro Passardi, Daniele Calistri, et al.Journal of Clinical Pathology|November 1, 2011
Detection of HER2 and Topo 2 in breast cancers: comparison between MLPA and FISH approachesSara Bravaccini, Claudia Rengucci, Laura Medri, et al.Molecular and Clinical Oncology|March 21, 2014
Target therapy in NSCLC patients: Relevant clinical agents and tumour molecular characterisationPaola Ulivi, Wainer Zoli, Laura Capelli, et al.BMC Cell Biology|January 28, 2006
Sequential events of apoptosis involving docetaxel, a microtubule-interfering agent: a cytometric studyFrancesco Fabbri, Silvia Carloni, Giovanni Brigliadori, et al.Analytical Cellular Pathology (Amsterdam)|May 19, 2012
Predictive role of telomerase activity in the clinical outcome of patients with benign lesions of the uterine cervix or CINSara Bravaccini, Andrea Amadori, Emanuela Scarpi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
In Vitro schedule-dependent interactions between the multitargeted antifolate LY231514 and gemcitabine in human colon adenocarcinoma cell linesAnna Tesei, Luca Ricotti, Franca De Paola, et al.International Journal of Molecular Sciences|May 18, 2013
Peripheral blood miR-328 expression as a potential biomarker for the early diagnosis of NSCLCPaola Ulivi, Giovanni Foschi, Marta Mengozzi, et al.International Journal of Oncology|September 6, 2007
Comparative evaluation of C1311 cytotoxic activity and interference with cell cycle progression in a panel of human solid tumour and leukaemia cell linesCinzia De Marco, Nadia Zaffaroni, Elizabeth Comijn, et al.Current Cancer Drug Targets|April 14, 2010
Tyrosine kinase inhibitors gefitinib, lapatinib and sorafenib induce rapid functional alterations in breast cancer cellsSilvia Carloni, Francesco Fabbri, Giovanni Brigliadori, et al.Pageof 10